Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

0.3995
Delayed Data
As of May 23
 -0.0134 / -3.25%
Today’s Change
0.39
Today|||52-Week Range
6.49
-86.46%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues61.3M84.9M121.7M175.9M
 
 
 
 
 
Cost of Goods Sold23.4M43.9M45.2M51.4M
 
 
 
 
 
Depreciation And Amortization3.2M8.7M33.0M94.7M
 
 
 
 
 
 
Operating ExpensesGross Income34.7M32.3M43.6M29.7M
 
 
 
 
 
General Expenses35.6M66.6M66.1M102.8M
 
 
 
 
 
Research And Development731.7K4.8M3.9M8.2M
 
 
 
 
 
Total Operating Expenses62.2M119.2M144.2M248.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-848.7K-34.3M-22.5M-73.0M
 
 
 
 
 
Extraordinary Credit0.0016.6M0.0019.5M
 
 
 
Extraordinary Charge-600.5K-28.0M-7.3M-49.0M
 
 
 
 
 
Pre-Tax Equity Earnings-240.2K0.000.00--
 
 
Interest Expense On Debt168.8K4.2M19.1M38.3M
 
 
 
 
 
Other Expenses0.003.4M-401.0K-582.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.8M-46.4M-49.0M-141.3M
 
 
 
 
 
Income Taxes-374.0K-20.8M-13.7M-7.1M
 
 
 
 
 
Net Income-1.4M-25.6M-35.3M-148.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS28.1M36.4M37.9M53.3M
 
 
 
 
 
Shares To Calculate EPS Diluted28.1M36.4M37.9M53.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.05-$0.70-$0.93-$2.78
 
 
 
 
 
EPS Diluted-$0.05-$0.70-$0.93-$2.78